Literature DB >> 11292486

Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.

A M Asemissen1, D Nagorsen, U Keilholz, A Letsch, A Schmittel, E Thiel, C Scheibenbogen.   

Abstract

The detection of antigen-induced IFNgamma secretion at the single cell level can be used to identify and enumerate antigen-reactive T cells from peripheral blood. This study was performed to analyze the suitability of T cell enumeration by flow cytometry in comparison with the ELISPOT assay. Peripheral blood mononuclear cell (PBMC) samples from six HLA-A2+ healthy subjects were analysed for the frequency of influenza-reactive CD8+ T cells by flow cytometry detecting either intracellular IFNgamma (IC-FC) or secreted IFNgamma (S-FC). All samples were also analysed by IFNgamma ELISPOT assay. The frequency of influenza peptide-reactive T cells determined by IC-FC was 0.01 to 0.34% of CD8+ T cells and by ELISPOT assay 0.02 to 0.23% of CD8+ T cells (n=6 subjects) with a high inter-assay reproducibility and a close correlation between the assays (r=0.77, P<0.001). Little or no IFNgamma production was observed in unstimulated PBMC samples using either the IC-FC or the ELISPOT assay. In contrast, using S-FC large numbers of IFNgamma-secreting CD8+ T cells (0.37% to 5.55%, n=6 subjects) were detected in unstimulated PBMC. The frequency of influenza-reactive CD8+ T cells (0.57-5.19%, n=6 subjects) determined by S-FC did not correlate with the values from the IC-FC or ELISPOT assays. This comparative study shows the suitability of the determination of frequencies of antigen reactive T cells in PBMC by IC-FC. The advantage of IC-FC is the possibility to phenotype simultaneously antigen-reactive T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292486     DOI: 10.1016/s0022-1759(01)00312-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  Activation of T lymphocytes in atherosclerotic plaques.

Authors:  Jean-Charles Grivel; Oxana Ivanova; Natalia Pinegina; Paul S Blank; Alexander Shpektor; Leonid B Margolis; Elena Vasilieva
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-29       Impact factor: 8.311

3.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

4.  Imaging of Protein Secretion from a Single Cell Using Plasmonic Substrates.

Authors:  Henryk Szmacinski; Vladimir Toshchakov; Wenji Piao; Joseph R Lakowicz
Journal:  Bionanoscience       Date:  2013-03-01

5.  Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.

Authors:  Dominique Chopin; Reza Barei-Moniri; Pascale Maillé; Marie-Aude Le Frère-Belda; Béatrice Muscatelli-Groux; Nicolò Merendino; Laure Lecerf; Antonella Stoppacciaro; Francesca Velotti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

6.  CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Authors:  Jennifer Serwanga; Susan Mugaba; Auma Betty; Edward Pimego; Sarah Walker; Paula Munderi; Charles Gilks; Frances Gotch; Heiner Grosskurth; Pontiano Kaleebu
Journal:  AIDS Res Treat       Date:  2011-01-18

7.  Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.

Authors:  Holden T Maecker; James Moon; Sonny Bhatia; Smita A Ghanekar; Vernon C Maino; Janice K Payne; Kristine Kuus-Reichel; Jennie C Chang; Amanda Summers; Timothy M Clay; Michael A Morse; H Kim Lyerly; Corazon DeLaRosa; Donna P Ankerst; Mary L Disis
Journal:  BMC Immunol       Date:  2005-07-18       Impact factor: 3.615

8.  Standardization of cytokine flow cytometry assays.

Authors:  Holden T Maecker; Aline Rinfret; Patricia D'Souza; Janice Darden; Eva Roig; Claire Landry; Peter Hayes; Josephine Birungi; Omu Anzala; Miguel Garcia; Alexandre Harari; Ian Frank; Ruth Baydo; Megan Baker; Jennifer Holbrook; Janet Ottinger; Laurie Lamoreaux; C Lorrie Epling; Elizabeth Sinclair; Maria A Suni; Kara Punt; Sandra Calarota; Sophia El-Bahi; Gailet Alter; Hazel Maila; Ellen Kuta; Josephine Cox; Clive Gray; Marcus Altfeld; Nolwenn Nougarede; Jean Boyer; Lynda Tussey; Timothy Tobery; Barry Bredt; Mario Roederer; Richard Koup; Vernon C Maino; Kent Weinhold; Giuseppe Pantaleo; Jill Gilmour; Helen Horton; Rafick P Sekaly
Journal:  BMC Immunol       Date:  2005-06-24       Impact factor: 3.615

9.  Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.

Authors:  Holden T Maecker; Jeffrey Hassler; Janice K Payne; Amanda Summers; Karrie Comatas; Manar Ghanayem; Michael A Morse; Timothy M Clay; Herbert K Lyerly; Sonny Bhatia; Smita A Ghanekar; Vernon C Maino; Corazon Delarosa; Mary L Disis
Journal:  BMC Immunol       Date:  2008-03-17       Impact factor: 3.615

10.  Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells.

Authors:  Lin Lin; Jacob Couturier; Xiaoying Yu; Miguel A Medina; Claudia A Kozinetz; Dorothy E Lewis
Journal:  BMC Immunol       Date:  2014-09-24       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.